Ersentilide

Last updated
Ersentilide
Ersentilide.svg
Names
IUPAC name
N-[4-[2-Hydroxy-3-[2-(4-imidazol-1-ylphenoxy)ethylamino]propoxy]phenyl]methanesulfonamide
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
PubChem CID
  • InChI=1S/C21H26N4O5S/c1-31(27,28)24-17-2-6-21(7-3-17)30-15-19(26)14-22-11-13-29-20-8-4-18(5-9-20)25-12-10-23-16-25/h2-10,12,16,19,22,24,26H,11,13-15H2,1H3
    Key: QZWUQVSQIFFFKY-UHFFFAOYSA-N
  • CS(=O)(=O)NC1=CC=C(C=C1)OCC(CNCCOC2=CC=C(C=C2)N3C=CN=C3)O
Properties
C21H26N4O5S
Molar mass 446.52 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Ersentilide is a beta adrenergic receptor antagonist. [1]

References

  1. ↑ Lombardi, F; Terranova, P (2006). "Pharmacological treatment of atrial fibrillation: Mechanisms of action and efficacy of class III drugs". Current Medicinal Chemistry. 13 (14): 1635–53. doi:10.2174/092986706777441940. PMID   16787210.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.